Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

611 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA: Position statement of the German Allergy Societies: Medical Association of German Allergologists (AeDA), German Society for Allergology and Clinical Immunology (DGAKI) and Society for Pediatric Allergology and Environmental Medicine (GPA).
Klimek L, Novak N, Hamelmann E, Werfel T, Wagenmann M, Taube C, Bauer A, Merk H, Rabe U, Jung K, Schlenter W, Ring J, Chaker A, Wehrmann W, Becker S, Mülleneisen N, Nemat K, Czech W, Wrede H, Brehler R, Fuchs T, Jakob T, Ankermann T, Schmidt SM, Gerstlauer M, Vogelberg C, Zuberbier T, Hartmann K, Worm M. Klimek L, et al. Among authors: zuberbier t. Allergo J Int. 2021;30(2):51-55. doi: 10.1007/s40629-020-00160-4. Epub 2021 Feb 24. Allergo J Int. 2021. PMID: 33643776 Free PMC article.
Efficacy and safety of intranasal medications for allergic rhinitis: Network meta-analysis.
Sousa-Pinto B, Vieira RJ, Bognanni A, Gil-Mata S, Ferreira-da-Silva R, Ferreira A, Cardoso-Fernandes A, Ferreira-Cardoso H, Marques-Cruz M, Duarte VH, Castro-Teles J, Campos-Lopes M, Teixeira-Ferreira A, Lourenço-Silva N, Chérrez-Ojeda I, Bedbrook A, Klimek L, Nuñez JJY, Zuberbier T, Fonseca JA, Schünemann HJ, Bousquet J; ARIA 2024 guideline panel. Sousa-Pinto B, et al. Among authors: zuberbier t. Allergy. 2024 Nov 16. doi: 10.1111/all.16384. Online ahead of print. Allergy. 2024. PMID: 39548801 Review.
GA2LEN ANACARE consensus statement: Potential of omalizumab in food allergy management.
Zuberbier T, Muraro A, Nurmatov U, Arasi S, Stevanovic K, Anagnostou A, Bonaguro R, Chinthrajah S, Lack G, Fiocchi A, Le TM, Turner P, Lozano MA, Angier E, Barni S, Bégin P, Ballmer-Weber B, Cardona V, Bindslev-Jensen C, Cianferoni A, de Jong N, de Silva D, Deschildre A, Galvin AD, Ebisawa M, Fleischer DM, Gerdts J, Giovannini M, Gradman J, Halken S, Arshad SH, Khaleva E, Lau S, Loh R, Mäkelä MJ, Marchisotto MJ, Morandini L, Mortz CG, Nilsson C, Nowak-Wegrzyn A, Podestà M, Poulsen LK, Roberts G, Rodríguez Del Río P, Sampson HA, Sánchez A, Schnadt S, Smith PK, Szajewska H, Mitrevska NT, Toniolo A, Venter C, Warner A, Wong GWK, Wood R, Worm M. Zuberbier T, et al. Clin Transl Allergy. 2024 Nov;14(11):e70002. doi: 10.1002/clt2.70002. Clin Transl Allergy. 2024. PMID: 39506193 Free PMC article. Review.
Intrinsic regulatory mechanisms protect human skin mast cells from excessive MRGPRX2 activation - paucity in LAD2 cells contributes to hyperresponsiveness of the mast cell line.
Li Z, Schneikert J, Bal G, Jin M, Franke K, Zuberbier T, Babina M. Li Z, et al. Among authors: zuberbier t. J Invest Dermatol. 2024 Oct 29:S0022-202X(24)02875-6. doi: 10.1016/j.jid.2024.10.593. Online ahead of print. J Invest Dermatol. 2024. PMID: 39481529 Free article. No abstract available.
Validity, reliability and responsiveness of digital visual analogue scales for chronic spontaneous urticaria monitoring: A CRUSE® mobile health study.
Sousa-Pinto B, Ramanauskaite A, Neisinger S, Witte-Händel E, Gimenez-Arnau AM, Guillet C, Parisi CAS, Katelaris CH, Fomina D, Larenas-Linnemann D, García E, Kocatürk E, Siebenhaar F, Lima H, Kaidashev I, Nasr I, Canales IO, Ojeda IC, Hébert J, Bousquet J, Bernstein JA, Peter J, Sanchez J, Sousa JIL, Kulthanan K, Weller K, Godse K, Rutkowski K, Lapina L, Bouillet L, Han LL, Ensina LF, Gonçalo M, Magerl M, van Doorn M, Metz M, Khoshkhui M, Hide M, Türk M, Kurjāne N, Conlon N, Salameh P, Kolkhir P, Asero R, Stepanenko R, Altrichter S, Gil-Mata S, Thomsen SF, Zuberbier T, Tsaryk V, Ye YM, Brzoza Z, Zhao Z, Maurer M. Sousa-Pinto B, et al. Among authors: zuberbier t. Allergy. 2024 Oct 24. doi: 10.1111/all.16371. Online ahead of print. Allergy. 2024. PMID: 39445583
Time to ACT-UP: Update on precautionary allergen labelling (PAL).
Turner PJ, Bognanni A, Arasi S, Ansotegui IJ, Schnadt S, La Vieille S, Hourihane JO, Zuberbier T, Eigenmann P, Ebisawa M, Morais-Almeida M, Barnett J, Martin B, Monaci L, Roberts G, Wong G, Gupta R, Tsabouri S, Mills C, Brooke-Taylor S, Bartra J, Levin M, Groetch M, Tanno L, Hossny E, Weber BB, Fierro V, Remington B, Gerdts J, Gowland MH, Chu D, Van Ravenhorst M, Koplin J, Fiocchi A; World Allergy Organization Consensus on the Use of PAL (ACT-UP!) Working Group. Turner PJ, et al. Among authors: zuberbier t. World Allergy Organ J. 2024 Sep 25;17(10):100972. doi: 10.1016/j.waojou.2024.100972. eCollection 2024 Oct. World Allergy Organ J. 2024. PMID: 39381624 Free PMC article. Review.
Impact of Allergic Rhinitis on Academic Performance in Adolescents and Adults: a Bayesian Analysis of MASK-air® Real-world Direct Patient Data.
Vieira RJ, Pereira AM, Papadopoulos NG, Zuberbier T, Pham-Thi N, Giovannini M, Melén E, Azevedo LF, Fonseca JA, Bousquet J, Sousa-Pinto B. Vieira RJ, et al. Among authors: zuberbier t. J Investig Allergol Clin Immunol. 2024 Sep 25:0. doi: 10.18176/jiaci.1010. Online ahead of print. J Investig Allergol Clin Immunol. 2024. PMID: 39319541 No abstract available.
611 results